108 related articles for article (PubMed ID: 33609860)
1. Different co-culture models reveal the pivotal role of TBBPA-promoted M2 macrophage polarization in the deterioration of endometrial cancer.
Jin X; Su H; Xu L; Wang Y; Su R; Zhang Z; Guan G; Li Z
J Hazard Mater; 2021 Jul; 413():125337. PubMed ID: 33609860
[TBL] [Abstract][Full Text] [Related]
2. TBBPA rather than its main derivatives enhanced growth of endometrial cancer via p53 ubiquitination.
Yu H; Zhang J; Liu J; Pan R; Wang Y; Jin X; Ahmed RZ; Zheng Y
J Environ Sci (China); 2024 Mar; 137():82-95. PubMed ID: 37980057
[TBL] [Abstract][Full Text] [Related]
3. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.
Rahal OM; Wolfe AR; Mandal PK; Larson R; Tin S; Jimenez C; Zhang D; Horton J; Reuben JM; McMurray JS; Woodward WA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1034-1043. PubMed ID: 29485045
[TBL] [Abstract][Full Text] [Related]
4. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
[No Abstract] [Full Text] [Related]
5. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA NIFK-AS1 inhibits M2 polarization of macrophages in endometrial cancer through targeting miR-146a.
Zhou YX; Zhao W; Mao LW; Wang YL; Xia LQ; Cao M; Shen J; Chen J
Int J Biochem Cell Biol; 2018 Nov; 104():25-33. PubMed ID: 30176290
[TBL] [Abstract][Full Text] [Related]
7. The promotion of tetrabromobisphenol A exposure on Ishikawa cells proliferation and pivotal role of ubiquitin-mediated IκB' degradation.
Guan G; Su H; Wei X; Zheng Y; Jin X
Ecotoxicol Environ Saf; 2021 Jan; 207():111254. PubMed ID: 32890954
[TBL] [Abstract][Full Text] [Related]
8. PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism.
Li N; Qin J; Lan L; Zhang H; Liu F; Wu Z; Ni H; Wang Y
Cancer Biol Ther; 2015; 16(2):297-306. PubMed ID: 25756512
[TBL] [Abstract][Full Text] [Related]
9. TBBPA stimulated cell migration of endometrial cancer via the contribution of NOX-generated ROS in lieu of energy metabolism.
Su H; Guan G; Ahmed RZ; Lyu L; Li Z; Jin X
J Hazard Mater; 2020 Dec; 400():123204. PubMed ID: 32569978
[TBL] [Abstract][Full Text] [Related]
10. CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer.
Gu S; Ni T; Wang J; Liu Y; Fan Q; Wang Y; Huang T; Chu Y; Sun X; Wang Y
J Immunol Res; 2018; 2018():6156757. PubMed ID: 30525058
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
12. MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway.
Chen W; Xu Y; Zhong J; Wang H; Weng M; Cheng Q; Wu Q; Sun Z; Jiang H; Zhu M; Ren Y; Xu P; Chen J; Miao C
Oncotarget; 2016 Nov; 7(48):78726-78735. PubMed ID: 27783989
[TBL] [Abstract][Full Text] [Related]
13. miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage.
Meng Z; Zhang R; Wang Y; Zhu G; Jin T; Li C; Zhang S
Int Immunopharmacol; 2020 Apr; 81():106028. PubMed ID: 31801690
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages.
Wei X; Nie S; Liu H; Sun J; Liu J; Li J; Li S; Wang S; Han S; Wang J; Sun Y
Am J Cancer Res; 2017; 7(11):2220-2233. PubMed ID: 29218246
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
Wang X; Gao S; Song L; Liu M; Sun Z; Liu J
Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900
[TBL] [Abstract][Full Text] [Related]
16. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer.
Li W; Zhang X; Wu F; Zhou Y; Bao Z; Li H; Zheng P; Zhao S
Cell Death Dis; 2019 Dec; 10(12):918. PubMed ID: 31801938
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma.
Bao L; Li X
Mol Cell Biochem; 2019 Oct; 460(1-2):67-79. PubMed ID: 31218569
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
19. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment.
Rebelo SP; Pinto C; Martins TR; Harrer N; Estrada MF; Loza-Alvarez P; Cabeçadas J; Alves PM; Gualda EJ; Sommergruber W; Brito C
Biomaterials; 2018 May; 163():185-197. PubMed ID: 29477032
[TBL] [Abstract][Full Text] [Related]
20. Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways.
Huang YJ; Yang CK; Wei PL; Huynh TT; Whang-Peng J; Meng TC; Hsiao M; Tzeng YM; Wu AT; Yen Y
J Hematol Oncol; 2017 Feb; 10(1):60. PubMed ID: 28241877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
